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ABSTRACT
Background: Contact allergy is a prevalent disorder. It
is estimated that about 20% of the general population
are allergic to one or more of the chemicals that
constitute the European baseline patch test panel.
While many studies have investigated associations
between type I allergic disorders and cancer, few have
looked into the association between cancer and
contact allergy, a type IV allergy. By linking two clinical
databases, the authors investigate the possible
association between contact allergy and cancer.
Methods: Record linkage of two different registers
was performed: (1) a tertiary hospital register of
dermatitis patients patch tested for contact allergy and
(2) a nationwide cancer register (the Danish Cancer
Register). After linking the two registers, only cancer
subtypes with 40 or more patients registered were
included in the analysis. The ﬁnal associations were
evaluated by logistic regression analysis.
Results: An inverse association between contact
allergy and non-melanoma skin- and breast cancer,
respectively, was identiﬁed in both sexes, and an
inverse trend for brain cancer was found in women
with contact allergy. Additionally, a positive association
between contact allergy and bladder cancer was found.
Conclusion: The inverse associations support the
immunosurveillance hypothesis (ie, individuals with an
allergy are less likely to get cancer due to a triggered
immune system), while the positive association with
bladder cancer could be due to accumulations of
chemical metabolites in the bladder. The authors’
ﬁndings add to the limited knowledge about contact
allergy and the risk of cancer.
INTRODUCTION
About 20% of Danish adults are contact-
allergic to chemicals and metals common in
the environment.
1 2 Contact allergy is caused
by skin contact with low-molecular-weight
non-protein chemicals, referred to as
haptens, and can progress to allergic contact
dermatitis if re-exposure exceeds the
individual’s threshold.
3 Allergic contact
dermatitis is a cutaneous delayed-type
hypersensitivity reaction mediated by hapten-
speciﬁc T cells.
4 A possible association
between type 1 allergic hypersensitivity reac-
tions, as observed in atopic diseases, and the
unrestrained cell growth in cancer has long
intrigued researchers. Some studies have
reported both positive and inverse associa-
tions for allergic disorders; others have not
found any signiﬁcant associations, as
reviewed in Sherman et al.
5 Most recent
epidemiological studies point towards atopic
diseases being associated with a reduced risk
of cancer.
6 However, a major problem
affecting many epidemiological studies on
associations between atopy and cancer is the
different way in which the studies deﬁne
atopy. Additionally, some studies have
included patients with allergic contact
dermatitis, which is problematic, as the
immune response differs greatly.
6 To date,
few studies have investigated the relationship
between contact allergy and cancer. Contact
allergy to metal dental restorations was found
to be a potential risk factor for intraoral
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ARTICLE SUMMARY
Article focus
- Cancer and allergy have previously been shown
to be associated. The associations are mostly
inverse, adding weight to the theory that
enhanced tumour immunosurveillance is
present in allergic individuals.
- The epidemiological studies showing these
ﬁndings were predominantly on type I allergy;
the present study investigated the association
between type IV allergy and cancer.
Key messages
- An association seemingly exists between contact
allergy and cancer. In light of previous ﬁndings of
an association between bladder cancer and
hair-dye use, the association between bladder
cancer and contact allergy we found is
interesting.
Strengths and limitations of this study
- This is a novel study investigating cancer and its
possible association with a type IV allergy. The
analysis was possible due to large, validated
patient registers.
- As this is not a prospective cohort study, it lacks
the ability to prove causation.
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7 and glioma appeared
inversely associated with self-reported contact derma-
titis.
8 Thus, it remains unclear whether two prevalent
disorders, cancer and contact allergy, are truly associ-
ated, and if so, in what direction. We have previously
shown that contact allergy is inversely associated with
autoimmune diseases such as type 1 diabetes and
inﬂammatory bowel disease.
9e11 This is a descriptive
exploratory investigation of the possible association
between contact allergy and cancer by using cross-
linkage between our contact allergy database and the
national cancer database (the Danish Cancer Registry).
MATERIALS AND METHODS
Study population and allergy testing
From November 1984 to December 2008, patch tests for
contact allergy using the European baseline series were
performed on 16922 (6113 men and 10809 women)
patients with dermatitis at the Department of Derma-
tology, Gentofte Hospital, Denmark. The outcome of
patch testing, sex and date of birth were recorded in the
allergy database. The European baseline series contains
the most prevalent contact allergens in the environment
for the European continent. Patch testing was
performed on the upper back using Trolab allergens
(Hermal, Reinbek, Germany) and Finn Chambers
(8 mm Epitest, Oy, Finland) on Scanpor tape
(Norgesplaster A/S, Alpharma, Vennesla, Norway) for
occlusion. Occlusion time was 48 h, and the patches
were read on Day 2, on Day 3 or 4, and on Day 5 or 7
according to international criteria from the Interna-
tional Contact Dermatitis Research Group (ICDRG).
12 13
A positive allergic reaction was deﬁned as at least
homogeneous erythema and inﬁltration in the test area.
The database contains information on the patch-test
reading result for each day, but in the present study,
a binary variable was constructed. Thus, a positive patch-
test reaction on any reading day to any allergen in the
European baseline series was considered positive. The
study population has been detailed previously.
14
Linkage study
At birth, or on immigration, all those with residency in
Denmark receive a unique and personal identiﬁer
number, a CPR number, which can be used for identiﬁ-
cation in databases. This enables linkage of individual
data between databases.
We used the unique identiﬁer number to link the
contact allergy database from Gentofte Hospital,
a tertiary referral centre, with the Danish Cancer
Registry, which contains codes of cancer diagnosis from
the International Classiﬁcation of Diseases, 7th or 10th
revision (ICD7 and ICD10). The Danish Cancer Registry
is a population-based registry containing nationwide
data on cancer cases since 1943. The history of the
Danish Cancer Registry was reviewed by Storm et al in
1997.
15 Cancer types were deﬁned according to the
Nordic Cancer Registries (NORDCAN Database, http://
www.ancr.nu/nordcan.asp). The cancer types ‘other
leukaemia’ and acute ‘leukaemia’ in the NORDCAN
database were omitted from data analyses, as we
considered the grouping ‘leukaemia’ to cover immuno-
logical aspects of this cancer type and be representative.
Table 1 shows cancer types used from the NORDCAN
database. Only cancer types for which we found 40 or
more patients after the linkage were included in the
logistic regression analyses. Age was calculated as the
age at ﬁrst positive patch-test outcome. When there
was no positive patch-test reading, the age at ﬁrst patch-
test procedure was used. Based on the number of
patients in different age groups, patients were stratiﬁed
into ﬁve groups: 0e29 years, 30e41 years, 42e52 years,
53e65 years and 65< years.
The combined data ﬁle was analysed using logistic
regression analysis with the patch-test outcome (contact
allergy: ‘yes’ vs ‘no’) as the dependent variable and
different cancer types as the independent variables, and
controlled for sex and age. Lastly, we inserted interaction
terms between sex and each cancer subtype (eg,
sex3colon cancer, sex3lung cancer, etc) in the regres-
sion analysis to test whether we should stratify the anal-
yses by sex. ORs with 95% CIs were estimated using
logistic regression. All data analyses were carried out
using SPSS version 18.
RESULTS
Among 16922 patients patch-tested in the selected
period, 6065 (35.8%) had a positive reaction to at least
one allergen on at least one occasion. The prevalence of
contact allergy, however, differed between the sexes, as
the prevalence was 26.1% in male patients and 41.4% in
female patients.
After linkage with the Danish Cancer Registry, 3200
(18.9%) dermatitis patients were identiﬁed with
a benign tumour and/or a malignant cancer diagnosis,
and 1207 (37.7%) of these also had a positive patch test
reaction. The distribution within different cancer
groups (with $40 cases) is shown in table 1. Crude data
analysis revealed a positive and signiﬁcant association
between being contact allergic and being registered in
the cancer registry (ManteleHaenszel common OR¼1.1;
p value¼0.014, 95% CI 1.02 to 1.20). Using logistic
regression analyses with contact allergy as the dependent
variable, we calculated ORs for different cancer groups
and adjusted the analysis for sex and age. Breast cancer
and non-melanoma skin cancer in both sexes were
found to be inversely and signiﬁcantly associated with
contact allergy; for women, there was a trend for an
inverse association between contact allergy and brain
cancer. Bladder cancer was found to be positively and
signiﬁcantly associated with contact allergy. The sex-
speciﬁc association for brain cancer was identiﬁed by
investigating different interaction terms between cancer
subtypes and sex. However, we found a signiﬁcant
interaction term only for brain/CNS cancer. Thus, when
a subsequent adjusted regression analysis was performed
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inverse association was found between brain/CNS
cancer and contact allergy (p¼0.080; OR¼0.36 (95%
CI¼0.12 to 1.13)). Table 2 shows the ORs for each
cancer type, adjusted for age and sex, and the ﬁnal
analysis outcome, which included bladder, breast, brain/
CNS and skin cancer (non-melanoma), as well as the
brain/cancer3sex interaction.
DISCUSSION
We found a signiﬁcant and inverse association
between contact allergy and breast cancer and
non-melanoma skin cancer, respectively, as well as
a signiﬁcant and positive association between
contact allergy and bladder cancer. Additionally,
brain/CNS cancer in women was inversely associ-
ated with contact allergy, albeit the p value was
above 0.050 (p value¼0.08).
The allergen database used in the study comprises
patients patch-tested at Gentofte hospital, and as such
the patch tests have been scored uniformly over the
years. The hospital lies in the capital region of Denmark,
a region where there is limited industrial exposure from
pesticide manufacturing, synthetic rubber processing,
petrochemical reﬁnery, etc, which gives no immediate
confounding due to working conditions known to cause
cancer.
We did not account for smoking in our study, although
smoking may increase the risk of developing nickel
contact allergy and some types of cancer.
16 17 However,
we found no association with lung or oral cancers, which
are positively associated with smoking,
18 but we did ﬁnd
a positive association with bladder cancer, which could
have been partially caused by smoking, as smoking is
a known risk factor for bladder cancer.
19 Smoking can
also be a risk factor for non-melanoma skin cancer,
20 21
Table 1 Sex-speciﬁc distribution of cancer types and contact allergy
Cancer groups
(NORDCAN)
Sex
Total
Men Women
No contact
allergy
Contact
allergy Total
No contact
allergy
Contact
allergy Total
Pancreas 11 4 15 13 17 30 45
24.4% 8.9% 33.3% 28.9% 37.8% 66.7% 100%
Brain/CNS 15 7 22 30 11 41 63
23.8% 11.1% 34.9% 47.6% 17.5% 65.1% 100%
Cervix uteri NA NA NA 34 30 64 64
53.1% 46.9% 100% 100%
Leukaemia 27 7 34 24 13 37 71
38.0% 9.9% 47.9% 33.8% 18.3% 52.1% 100%
Lip, oral cavity and pharynx 30 15 45 16 12 28 73
41.1% 20.5% 61.6% 21.9% 16.4% 38.4% 100%
Corpus uteri NA NA NA 48 38 86 86
55.8% 44.2% 100% 100%
Rectum and anus 41 14 55 29 17 46 101
40.6% 13.9 54.5% 28.7% 16.8% 45.5% 100%
Melanoma of skin 32 11 43 40 21 61 104
30.8% 10.6% 41.3% 38.5% 20.2% 58.7% 100%
Prostate 86 36 122 NA NA NA 122
70.5% 29.5% 100% 100%
Colon 43 9 52 43 29 72 124
34.7% 7.3% 41.9% 34.7% 23.4% 58.1% 100%
Bladder, etc 63 33 96 21 22 43 139
45.3% 23.7% 69.1% 15.1% 15.8% 30.9% 100%
Lung 83 26 109 41 42 83 192
43.2% 13.5% 56.8% 21.4% 21.9% 43.2% 100%
Colorectal 83 23 106 71 46 117 223
37.2% 10.3% 47.5% 31.8% 20.6% 52.5% 100%
Breast 0 0 0 248 151 399 399
62.2% 37.8% 100% 100%
Skin, non-melanoma 203 72 275 284 166 450 725
28.0% 9.9% 37.9% 39.2% 22.9% 62.1% 100%
All sites but non-melanoma
skin cancer
531 209 740 663 452 1115 1855
28.6% 11.3% 39.9% 35.7% 24.4% 60.1% 100%
Total (allergy database) 4519 1594 6113 4471 6338 10809 16922
26.7% 9.4% 36.1% 26.4% 37.5% 63.9% 100%
The cancer types are sorted ascendingly according to the total number of patients with the respective cancer type. Only cancer types with $40
patients were included in the logistic regression analyses. CNS, central nervous system.
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22 23 and is specu-
lated to be a risk factor for breast cancer.
24 However, as
these cancer types were inversely associated with contact
allergy, a bias caused by smoking would have weakened
the association.
Although most patients with contact allergy have been
treated intermittently with topical steroids, only
a minority have been treated with systemic immuno-
suppressants. The latter treatment might be associated
with non-melanoma skin cancer, as TNF-a-inhibitors and
prednisolone have been shown to increase the risk of
non-melanoma skin cancer in rheumatoid-arthritis
patients.
25 Additionally, a study on squamous-cell carci-
noma found a positive association in patients hospital-
ised for chronic diseases, including skin disease and
among these allergic contact dermatitis.
26 In our study,
we found an inverse association between contact allergy
and non-melanoma skin cancer, and treatment biases
could therefore have weakened this inverse association.
Self-reported contact eczema has been found to be
inversely correlated to glioma and meningioma.
8 The
self-reported contact eczema had the lowest OR of any of
the allergic conditions for both glioma and meningioma,
although the CI for meningioma was wide and close to 1.
Glioma patients have been shown to have impaired
immunity,
27 and it is unknown whether the suppression
is evident before diagnosis of the tumour. It has been
suggested that hair dyeing can increase the risk of
glioma
28 29; however, we found an inverse association,
even though hair dyeing is a risk factor for development
of p-phenylenediamine contact allergy, for example.
Hair dyeing may also be a risk factor for developing
bladder cancer.
30 31 In our study, we found a positive
association between contact allergy and bladder cancer,
which may be caused by p-phenylenediamine contact
allergy. Hair dyeing does not appear to be related to
breast cancer.
32
It would have been interesting if we had analysed
possible associations between speciﬁc allergens and
cancer types in the current dataset, but owing to a lack of
power, this was not possible.
Various hypotheses have been put forward to explain
the associations between allergy and cancer. The ‘anti-
genic stimulation’ hypothesis has been suggested to
explain positive associations. In this hypothesis, it is
speculated that the increased stimulation of cell growth
in allergy and chronic inﬂammation increases the like-
lihood of mutation of dividing stem cells and malignant
proliferation.
5 To explain inverse associations, the
immunosurveillance hypothesis has been suggested,
where the allergic symptoms are the side effect of
hyperimmunity. Additionally, tumours may suppress the
immune system systemically and in the microenviron-
ment of the tumour,
33 as seen in glioma patients, who
have a lower count of CD4+T cells overall and an
increased fraction of CD4+FOXP3+T cells in the
remaining fraction.
34
In conclusion, contact allergy was found to be associated
with four different cancer subtypes. Most of the associa-
tions were inverse, which might support the immuno-
surveillance hypothesis. The reason for these relations is
u n c e r t a i na n dn o tn e c e s s a r i l yt h er e s u l to fc a u s a l i t y .M o r e
Table 2 Logistic analysis for the individual cancer group adjusted for age and sex
Cancer groups
(NORDCAN) p Value OR (95% CI)
Pancreas 0.184 1.50 (0.83 to 2.72)
Brain/CNS 0.159 0.66 (0.38 to 1.16)
Cervix uteri 0.503 1.18 (0.73 to 1.94)
Leukaemia 0.233 0.73 (0.43 to 1.23)
Lip, oral cavity and pharynx 0.496 1.18 (0.73 to 1.92)
Corpus uteri 0.797 1.06 (0.69 to 1.62)
Rectum and anus 0.470 0.85 (0.55 to 1.31)
Melanoma of skin 0.262 0.79 (0.51 to 1.20)
Prostate 0.455 1.16 (0.78 to 1.73)
Colon 0.215 0.78 (0.53 to 1.15)
Bladder, etc 0.039 1.44 (1.02 to 2.05)
Lung 0.720 1.06 (0.78 to 1.43)
Colorectal 0.187 0.82 (0.61 to 1.10)
Breast 0.031 0.80 (0.65 to 0.98)
Skin, non-melanoma 0.020 0.82 (0.70 to 0.97)
All sites but non-melanoma skin cancer 0.415 0.96 (0.86 to 1.06)
Final logistic analysis
Bladder, etc 0.040 1.44 (1.02 to 2.05)
Breast 0.035 0.80 (0.65 to 0.98)
Skin, non-melanoma 0.021 0.83 (0.70 to 0.97)
Brain/CNS 0.513 1.35 (0.55 to 3.33)
Brain/CNS3sex 0.080 0.36 (0.12 to 1.13)
The last six rows are the ﬁnal analysis outcome with the interaction variable and the signiﬁcant cancer groups. CNS, central nervous system.
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Association between cancer and contact allergyreﬁned analyses, adjusting for social class and smoking, for
instance, and studies focusing on speciﬁc chemical expo-
sures are required to further our understanding of the role
of contact allergies in the devel o p m e n to fc a n c e r .H o w e v e r ,
if these relations are aetiological, there are implications for
understanding how contact allergy can affect cancer
development and vice versa.
Our ﬁndings add to the limited knowledge of the
association between contact allergy and cancer.
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